The Gatekeepers Lizzy Lawrence STAT Plus: How the CEO of the largest medical device accelerator molds medtech startups
Health tech Lizzy Lawrence STAT Plus: FDA approves Medtronic high blood pressure device despite a negative advisory panel vote
Health tech Lizzy Lawrence STAT Plus: A digital pill shows early promise in detecting opioid overdose, sleep apnea
Health tech Lizzy Lawrence STAT Plus: NYU researchers tackle the challenge of making MRI machines less expensive
Health Matthew Herper STAT Plus: After decades in use, heart stents finally beat placebo. It took a bold researcher
Health tech Mohana Ravindranath STAT Plus: FTC’s Lina Khan makes a stop at Y Combinator, how telehealth helps rural America
Health tech Lizzy Lawrence STAT Plus: Experts talk detecting disease from voice biomarkers with AI, privacy concerns
Health tech Lizzy Lawrence STAT Plus: Inari Medical to buy last-line amputation prevention company LimFlow
Health tech Mario Aguilar STAT Plus: Teladoc stock slides despite business growth, Medtronic CEO talks innovation
Health tech Lizzy Lawrence STAT Plus: Boston Scientific’s drug-coated balloon may reduce risk of heart attack
Health tech Lizzy Lawrence STAT Plus: Medtronic CEO talks latest bets on diabetes, high blood pressure technology
Health tech Lizzy Lawrence STAT Plus: FDA’s warning to J&J’s Abiomed signals a crackdown on digital health tools
Health tech Lizzy Lawrence STAT Plus: Key takeaways from AdvaMed, the world’s largest medical device conference
Health tech Lizzy Lawrence STAT Plus: To prevent amputation in patients with severe vascular disease, a device turns veins into arteries
Health tech Lizzy Lawrence STAT Plus: Former FDA official lays out how to keep patients safe from risky medical devices
In the Lab Annalisa Merelli Octopus tentacles inspired a new drug delivery patch that sticks to the inside of your cheek
Health tech Lizzy Lawrence STAT Plus: FDA panel votes against GLP-1 therapy from former diabetes unicorn Intarcia
The Readout LOUD Damian Garde and Allison DeAngelis A thorny ALS debate at the FDA, and the promise of artificial wombs
Health tech Lizzy Lawrence STAT Plus: FDA weighs animal data, ethical dilemmas at panel on artificial wombs
Health tech Lizzy Lawrence STAT Plus: Artificial wombs, after years in development, reach FDA review for human trials
Pharma Associated Press STAT Plus: Johnson & Johnson is getting rid of its script logo after more than 130 years
Health tech Lizzy Lawrence STAT Plus: FDA proposes changes to key approval pathway for medical devices, five years after promising
Health tech Lizzy Lawrence STAT Plus: As competition looms, Insulet sues a rival for allegedly stealing trade secrets on diabetes tech
Health tech Lizzy Lawrence STAT Plus: FDA panel votes against high blood pressure device from Medtronic, but lends support to ReCor Medical’s
Health tech Lizzy Lawrence STAT Plus: FDA advisory panel to debate contentious data on Medtronic’s high blood pressure device
Special Report Bob Herman, J. Emory Parker, Adam Feuerstein, Lizzy Lawrence, and Mohana Ravindranath STAT Plus: Health care CEOs hauled in $4 billion last year as inflation pinched workers, analysis shows